← Eichor
Study identifier: NCT05552352 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

Condition: Severe Aortic Valve Stenosis  ·  Sponsor: Heinrich-Heine University, Duesseldorf

PhaseNA
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.

This description comes directly from the study's public registry record.

Talk to the study team

Christian Jung, Prof MD PhD  ·  +49 211 81  ·  christian.jung@med.uni-duesseldorf.de

Raphael Bruno, MD  ·  +49 211 81  ·  raphael.bruno@med.uni-duesseldorf.de

Always discuss trial participation with your own doctor first.

Locations (2)

Universitätsklinikum Düsseldorf, Klinik für Kardiologie, Pneumologie & AngiologieDüsseldorf, North Rhine-Westphalia, GermanyRecruiting
Universitätsklinikum Köln, Klinik III für Innere Medizin, Herzzentrum, Kerpener Straße 62Cologne, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05552352